WallStSmart

Pubmatic Inc (PUBM)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Pubmatic Inc generates 9% more annual revenue ($282.93M vs $258.90M). PUBM leads profitability with a -5.1% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

PUBM

Hold

37

out of 100

Grade: F

Growth: 2.7Profit: 3.0Value: 5.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PUBMUndervalued (+76.3%)

Margin of Safety

+76.3%

Fair Value

$27.80

Current Price

$9.78

$18.02 discount

UndervaluedFair: $27.80Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PUBM1 strengths · Avg: 8.0/10
Price/BookValuation
1.7x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

PUBM4 concerns · Avg: 2.3/10
Market CapQuality
$463.63M3/10

Smaller company, higher risk/reward

PEG RatioValuation
5.342/10

Expensive relative to growth rate

Return on EquityProfitability
-5.4%2/10

ROE of -5.4% — below average capital efficiency

Revenue GrowthGrowth
-6.4%2/10

Revenue declined 6.4%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : PUBM

The strongest argument for PUBM centers on Price/Book.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : PUBM

The primary concerns for PUBM are Market Cap, PEG Ratio, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

PUBM profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 37/100) and 43.0% revenue growth. PUBM offers better value entry with a 76.3% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Pubmatic Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

PubMatic, Inc. provides a cloud infrastructure platform that enables real-time programmatic ad transactions for Internet content creators and advertisers around the world. The company is headquartered in Redwood City, California.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?